Biopharmaceutics Risk Assessment During Formulation and Clinical Development

09:50 - 10:25

 

  • Role of in vitro, in silico and in vivo tools in formulation develop: Case Studies
  • Combination of preclinical data with modelling and simulation to inform clinical formulation selection
  • Driving Quality by Design via Biopharmaceutics Risk Assessment: Case Studies

Filippos Kesisoglou, Senior Principal Scientist, Biopharmaceutics and Pharmaceutical Sciences, MSD